Non-statin LDL-lowering drugs have less impressive cardiac outcome data than statins.

“the data in terms of cardiac outcomes I believe is even less impressive when we're looking at drugs that lower LDL that are in Staten class because as people will know there are many drugs that lower LDL that are not statins that are not hmg-coa reductase inhibitors there's cholestyramine there's zetia there's many drugs that lower LDL they're not statins and what what do we see with those drugs just briefly what do we see with those drugs in terms of cardiac outcomes that are not statins”